Blood tests could personalize breast cancer radiation
NCT ID NCT04308720
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how radiation therapy for breast cancer affects tumor DNA and immune cells in the blood. Researchers will track these markers in 217 patients to see if they can predict treatment response. The goal is to use this information to customize radiation plans in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors tailor radiation therapy for breast cancer patients based on blood markers.
- What could go wrong
- This is an observational study, not testing a new treatment. Results may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?